{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:22:08Z","timestamp":1790821328751,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.carrev.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T20:20:03Z","timestamp":1586809203000},"page":"1150-1154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years"],"prefix":"10.1016","volume":"21","author":[{"given":"Michael","family":"Haude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kische","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Toelg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas M.","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Verheye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evald H\u00f8j","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.04.006_bb0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2016.11.055","article-title":"10-year clinical outcome after randomization to treatment by sirolimus- or paclitaxel-eluting coronary stents","volume":"69","author":"Gall\u00f8e","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 9","key":"10.1016\/j.carrev.2020.04.006_bb0010","doi-asserted-by":"crossref","first-page":"S923","DOI":"10.21037\/jtd.2017.06.30","article-title":"Mechanical behavior of polymer-based vs. metallic-based bioresorbable stents","volume":"9","author":"Ang","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.carrev.2020.04.006_bb0015","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.4244\/EIJ20170912-01","article-title":"Report of an ESC-EAPCI task force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary","volume":"13","author":"Byrne","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.006_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4244\/EIJ-D-18-00607","article-title":"How does the failure of absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials","volume":"15","author":"Katagiri","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.006_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4244\/EIJV15I1A5","article-title":"Should we stop using bioresorbable scaffolds in coronary revascularisation?","volume":"15","author":"Mangieri","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.006_bb0030","article-title":"ESC\/EACTS guidelines on myocardial revascularization","volume":"2018","author":"Neumann","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.006_bb0035","article-title":"Mechanical properties of the drug-eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug-eluting stent","author":"Barkholt","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.006_bb0040","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4244\/EIJ-D-17-00254","article-title":"Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III","volume":"13","author":"Haude","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.006_bb0045","article-title":"Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III","author":"Haude","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.006_bb0050","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.006_bb0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies","volume":"5","author":"Vranckx","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.006_bb0060","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.006_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial","volume":"387","author":"Haude","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2020.04.006_bb0070","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/eurheartj\/ehw196","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","volume":"37","author":"Haude","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2020.04.006_bb0075","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10554-017-1124-0","article-title":"Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds","volume":"33","author":"Tenekecioglu","year":"2017","journal-title":"Int J Cardiovasc Imaging."},{"key":"10.1016\/j.carrev.2020.04.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.carrev.2019.02.003","article-title":"Magnesium 2000 postmarket evaluation: guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold","author":"Wlodarczak","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.04.006_bb0085","article-title":"Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry","author":"Verheye","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2020.04.006_bb0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.117.031843","article-title":"Three-year outcomes with the Absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials","volume":"137","author":"Ali","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.04.006_bb0095","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1253\/circj.CJ-18-0795","article-title":"Magmaris bioresorbable scaffold - possible dismantling 2 months after implantation on intravascular ultrasound","volume":"83","author":"Mitomo","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2020.04.006_bb0100","first-page":"310","article-title":"Early collapse causing stenosis in a resorbable magnesium scaffold","volume":"92","author":"Marynissen","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.006_bb0105","article-title":"Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold","author":"Tovar Forero","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.006_bb0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carrev.2019.02.019","volume":"20","author":"Hideo-Kajita","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.04.006_bb0115","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","author":"Haude","year":"2019","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920301809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920301809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:19:30Z","timestamp":1761560370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920301809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1553838920301809"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.04.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}